CTLA4 and colonic neoplasm: CT26 is a N-nitroso-N-methylurethane-induced, undifferentiated colon carcinoma cell line and recent cancer immunotherapy studies have shown that CTLA-4 blockade reduced CT26 colon tumor size and was effective in CT26 tumor models [27], [28].